Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cryosurgery | 24 | 2024 | 474 | 4.880 |
Why?
|
Liver Neoplasms | 27 | 2024 | 4309 | 3.650 |
Why?
|
Ablation Techniques | 10 | 2021 | 247 | 3.350 |
Why?
|
Radiography, Interventional | 21 | 2021 | 1122 | 2.750 |
Why?
|
Catheter Ablation | 18 | 2024 | 2751 | 2.240 |
Why?
|
Fluorodeoxyglucose F18 | 14 | 2021 | 2024 | 1.930 |
Why?
|
Microwaves | 10 | 2023 | 184 | 1.730 |
Why?
|
Radiology, Interventional | 7 | 2020 | 477 | 1.640 |
Why?
|
Positron-Emission Tomography | 17 | 2023 | 6585 | 1.410 |
Why?
|
Tomography, X-Ray Computed | 39 | 2023 | 20588 | 1.300 |
Why?
|
Surgery, Computer-Assisted | 8 | 2020 | 1003 | 0.980 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2024 | 54 | 0.860 |
Why?
|
Kidney Neoplasms | 9 | 2023 | 4251 | 0.780 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2023 | 2293 | 0.760 |
Why?
|
Cholangiocarcinoma | 3 | 2023 | 554 | 0.720 |
Why?
|
Bile Duct Neoplasms | 2 | 2023 | 607 | 0.700 |
Why?
|
Radiation Dosage | 7 | 2022 | 1962 | 0.620 |
Why?
|
Nitrogen Radioisotopes | 1 | 2018 | 43 | 0.620 |
Why?
|
Radiopharmaceuticals | 9 | 2021 | 2683 | 0.610 |
Why?
|
Ascites | 2 | 2017 | 338 | 0.600 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 2017 | 41 | 0.560 |
Why?
|
Magnetic Resonance Imaging, Interventional | 3 | 2017 | 187 | 0.550 |
Why?
|
Retrospective Studies | 37 | 2024 | 80674 | 0.460 |
Why?
|
Radiology Department, Hospital | 1 | 2017 | 407 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 17 | 2023 | 36415 | 0.440 |
Why?
|
Neoplasms | 6 | 2024 | 22140 | 0.410 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1164 | 0.400 |
Why?
|
Contrast Media | 8 | 2023 | 5311 | 0.400 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 273 | 0.390 |
Why?
|
Quality Assurance, Health Care | 4 | 2017 | 2164 | 0.390 |
Why?
|
Occupational Exposure | 1 | 2022 | 1814 | 0.390 |
Why?
|
Lung Neoplasms | 10 | 2023 | 13385 | 0.380 |
Why?
|
Hemorrhage | 1 | 2023 | 3422 | 0.380 |
Why?
|
Therapy, Computer-Assisted | 1 | 2013 | 265 | 0.380 |
Why?
|
Crohn Disease | 3 | 2017 | 2278 | 0.370 |
Why?
|
Treatment Outcome | 29 | 2024 | 64681 | 0.370 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2014 | 1221 | 0.370 |
Why?
|
Artifacts | 2 | 2016 | 1912 | 0.360 |
Why?
|
Aged, 80 and over | 26 | 2023 | 58952 | 0.350 |
Why?
|
Aged | 47 | 2023 | 169288 | 0.340 |
Why?
|
Diagnostic Imaging | 4 | 2024 | 3534 | 0.340 |
Why?
|
Radiosurgery | 1 | 2018 | 1339 | 0.320 |
Why?
|
Gadolinium DTPA | 3 | 2023 | 823 | 0.320 |
Why?
|
Middle Aged | 49 | 2023 | 220853 | 0.310 |
Why?
|
Humans | 88 | 2024 | 761208 | 0.310 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2019 | 732 | 0.300 |
Why?
|
Tomography, Emission-Computed | 1 | 2010 | 1123 | 0.290 |
Why?
|
Biopsy, Needle | 4 | 2020 | 1624 | 0.280 |
Why?
|
Adult | 40 | 2023 | 221119 | 0.280 |
Why?
|
Liver | 5 | 2021 | 7514 | 0.280 |
Why?
|
Predictive Value of Tests | 11 | 2020 | 15308 | 0.260 |
Why?
|
Kidney Diseases | 1 | 2016 | 2092 | 0.260 |
Why?
|
Sensitivity and Specificity | 10 | 2023 | 14675 | 0.240 |
Why?
|
Biopsy | 5 | 2017 | 6781 | 0.240 |
Why?
|
Respiration | 1 | 2011 | 1656 | 0.240 |
Why?
|
Medical Audit | 2 | 2016 | 452 | 0.230 |
Why?
|
Databases, Factual | 2 | 2016 | 7966 | 0.230 |
Why?
|
Kidney | 4 | 2023 | 7033 | 0.230 |
Why?
|
Surgical Instruments | 2 | 2017 | 383 | 0.230 |
Why?
|
Fluoroscopy | 4 | 2023 | 947 | 0.230 |
Why?
|
Female | 51 | 2023 | 392544 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2023 | 9278 | 0.220 |
Why?
|
Cautery | 1 | 2023 | 71 | 0.220 |
Why?
|
Carcinoma, Renal Cell | 4 | 2023 | 3163 | 0.210 |
Why?
|
Portal Vein | 2 | 2016 | 432 | 0.200 |
Why?
|
Male | 50 | 2023 | 360693 | 0.200 |
Why?
|
Postoperative Complications | 5 | 2019 | 15637 | 0.200 |
Why?
|
Ice | 1 | 2023 | 102 | 0.200 |
Why?
|
Subtraction Technique | 3 | 2016 | 518 | 0.190 |
Why?
|
Medical Oncology | 1 | 2013 | 2320 | 0.190 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 297 | 0.190 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5321 | 0.190 |
Why?
|
Gallbladder | 2 | 2014 | 308 | 0.190 |
Why?
|
Inhibins | 1 | 2021 | 211 | 0.180 |
Why?
|
Pulmonary Edema | 1 | 2023 | 408 | 0.180 |
Why?
|
Digestive System Neoplasms | 2 | 2011 | 83 | 0.180 |
Why?
|
Adenoma, Islet Cell | 1 | 2000 | 72 | 0.170 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2021 | 262 | 0.150 |
Why?
|
Radiometry | 3 | 2017 | 812 | 0.150 |
Why?
|
Tumor Burden | 4 | 2016 | 1892 | 0.150 |
Why?
|
Sarcopenia | 1 | 2022 | 370 | 0.150 |
Why?
|
Motion | 2 | 2021 | 779 | 0.140 |
Why?
|
Drainage | 3 | 2017 | 1157 | 0.140 |
Why?
|
Pilot Projects | 5 | 2019 | 8642 | 0.130 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 128 | 0.130 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2016 | 105 | 0.130 |
Why?
|
Perfusion | 1 | 2021 | 1390 | 0.130 |
Why?
|
Hepatic Veins | 1 | 2016 | 112 | 0.130 |
Why?
|
Paracentesis | 1 | 2016 | 98 | 0.130 |
Why?
|
Needles | 3 | 2017 | 453 | 0.130 |
Why?
|
Digestive System Diseases | 1 | 2017 | 151 | 0.130 |
Why?
|
Venous Thrombosis | 2 | 2016 | 1304 | 0.130 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 2015 | 30 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2023 | 5250 | 0.120 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5366 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2016 | 20119 | 0.120 |
Why?
|
Catecholamines | 1 | 2015 | 387 | 0.120 |
Why?
|
Urologic Diseases | 1 | 2017 | 247 | 0.120 |
Why?
|
Myoglobinuria | 1 | 2014 | 22 | 0.120 |
Why?
|
Quality Improvement | 3 | 2020 | 3808 | 0.110 |
Why?
|
Pleural Effusion | 1 | 2017 | 341 | 0.110 |
Why?
|
Adrenalectomy | 1 | 2015 | 346 | 0.110 |
Why?
|
Inhalation | 1 | 2014 | 143 | 0.110 |
Why?
|
Neoplasm Seeding | 1 | 2013 | 84 | 0.110 |
Why?
|
Nephrectomy | 1 | 2018 | 938 | 0.110 |
Why?
|
Respiratory Mechanics | 1 | 2016 | 698 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2021 | 8998 | 0.100 |
Why?
|
Boston | 4 | 2014 | 9327 | 0.100 |
Why?
|
Adrenal Glands | 1 | 2015 | 552 | 0.100 |
Why?
|
Catheterization | 1 | 2017 | 1428 | 0.100 |
Why?
|
Pouchitis | 1 | 2012 | 64 | 0.100 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 287 | 0.100 |
Why?
|
Angiomyolipoma | 1 | 2013 | 188 | 0.100 |
Why?
|
Ultrasonography, Interventional | 2 | 2017 | 1496 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6486 | 0.090 |
Why?
|
Hepatectomy | 2 | 2014 | 557 | 0.090 |
Why?
|
Colonic Pouches | 1 | 2012 | 122 | 0.090 |
Why?
|
Body Burden | 1 | 2011 | 158 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2014 | 3366 | 0.090 |
Why?
|
Colonic Diseases | 1 | 2012 | 201 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2020 | 1789 | 0.090 |
Why?
|
Proctocolectomy, Restorative | 1 | 2012 | 190 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1800 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 386 | 0.090 |
Why?
|
Prospective Studies | 8 | 2018 | 54435 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 2010 | 6919 | 0.090 |
Why?
|
Diatrizoate Meglumine | 1 | 1989 | 79 | 0.090 |
Why?
|
False Negative Reactions | 1 | 2010 | 573 | 0.080 |
Why?
|
Anesthesia, General | 1 | 2016 | 1174 | 0.080 |
Why?
|
Consensus | 2 | 2020 | 3134 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 1992 | 534 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2010 | 958 | 0.080 |
Why?
|
Anticoagulants | 1 | 2023 | 4795 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3201 | 0.070 |
Why?
|
Sutures | 1 | 2010 | 282 | 0.070 |
Why?
|
Gastroplasty | 1 | 2009 | 157 | 0.070 |
Why?
|
Survival Rate | 2 | 2018 | 12728 | 0.070 |
Why?
|
Time Factors | 4 | 2020 | 39957 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1910 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1726 | 0.070 |
Why?
|
Disease Progression | 4 | 2019 | 13511 | 0.070 |
Why?
|
Decompression, Surgical | 1 | 2012 | 607 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2051 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4340 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5869 | 0.070 |
Why?
|
Adipose Tissue | 2 | 2013 | 3313 | 0.060 |
Why?
|
Lymphoma | 2 | 2021 | 1898 | 0.060 |
Why?
|
Suction | 2 | 2017 | 266 | 0.060 |
Why?
|
Blindness | 1 | 1989 | 585 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3727 | 0.060 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2008 | 279 | 0.060 |
Why?
|
Anesthesiology | 1 | 2015 | 1122 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4246 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 1989 | 1281 | 0.060 |
Why?
|
Spinal Cord Compression | 1 | 1986 | 234 | 0.060 |
Why?
|
Genetic Variation | 1 | 2018 | 6567 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 24021 | 0.050 |
Why?
|
Ependymoma | 1 | 1986 | 320 | 0.050 |
Why?
|
Colonoscopy | 1 | 2010 | 1395 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5828 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2894 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9416 | 0.050 |
Why?
|
Nephrons | 1 | 2023 | 168 | 0.050 |
Why?
|
Lung | 4 | 2023 | 9979 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1908 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 74239 | 0.050 |
Why?
|
Gastric Bypass | 1 | 2009 | 818 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4909 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4052 | 0.040 |
Why?
|
Thorax | 1 | 2023 | 555 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2024 | 767 | 0.040 |
Why?
|
Liver Transplantation | 1 | 1992 | 2332 | 0.040 |
Why?
|
Incidence | 3 | 2016 | 21365 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4822 | 0.040 |
Why?
|
Ultrasonography | 3 | 2023 | 5969 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2021 | 880 | 0.040 |
Why?
|
Obesity, Morbid | 1 | 2009 | 1277 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2008 | 1658 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10088 | 0.040 |
Why?
|
Laparoscopy | 1 | 2009 | 2035 | 0.040 |
Why?
|
Anesthesia | 1 | 2009 | 1591 | 0.040 |
Why?
|
Nuclear Medicine | 1 | 2021 | 257 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2017 | 359 | 0.040 |
Why?
|
Equipment Design | 2 | 2017 | 3510 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15520 | 0.030 |
Why?
|
Models, Statistical | 1 | 2011 | 5081 | 0.030 |
Why?
|
Meningeal Neoplasms | 1 | 1986 | 1246 | 0.030 |
Why?
|
Current Procedural Terminology | 1 | 2016 | 89 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 251 | 0.030 |
Why?
|
Online Systems | 1 | 2016 | 182 | 0.030 |
Why?
|
Image Enhancement | 2 | 2009 | 2888 | 0.030 |
Why?
|
United States | 3 | 2016 | 72339 | 0.030 |
Why?
|
Pressure | 1 | 2017 | 1155 | 0.030 |
Why?
|
Bile Ducts | 1 | 2014 | 284 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2016 | 529 | 0.020 |
Why?
|
Hyperplasia | 1 | 2015 | 1150 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3584 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1480 | 0.020 |
Why?
|
Preoperative Period | 1 | 2013 | 551 | 0.020 |
Why?
|
Algorithms | 3 | 2021 | 14025 | 0.020 |
Why?
|
Bile | 1 | 2012 | 297 | 0.020 |
Why?
|
Young Adult | 3 | 2017 | 59221 | 0.020 |
Why?
|
Cost Savings | 1 | 2016 | 911 | 0.020 |
Why?
|
Patient Positioning | 1 | 2013 | 326 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3461 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
Radiologic Health | 1 | 2009 | 4 | 0.020 |
Why?
|
Documentation | 1 | 2016 | 900 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1852 | 0.020 |
Why?
|
Relative Biological Effectiveness | 1 | 2011 | 311 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2854 | 0.020 |
Why?
|
Quality Control | 1 | 2012 | 833 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1743 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1436 | 0.020 |
Why?
|
Uncertainty | 1 | 2014 | 752 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3881 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1989 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39126 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1807 | 0.020 |
Why?
|
Length of Stay | 1 | 2022 | 6417 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2041 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 982 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2527 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2610 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4111 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2012 | 876 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3821 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2009 | 549 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 1986 | 134 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3923 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12474 | 0.010 |
Why?
|
Cohort Studies | 2 | 2021 | 41496 | 0.010 |
Why?
|
Postoperative Period | 1 | 2009 | 1818 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 12976 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18384 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1597 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9652 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 1989 | 1027 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4303 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2009 | 993 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 1989 | 877 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3453 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6974 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12052 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8530 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8519 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13249 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29687 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11119 | 0.010 |
Why?
|
Meningioma | 1 | 1986 | 1216 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22174 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12952 | 0.010 |
Why?
|
Adolescent | 1 | 2000 | 88298 | 0.010 |
Why?
|
Color | 1 | 1989 | 297 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1986 | 9025 | 0.000 |
Why?
|
Aortic Aneurysm | 1 | 1989 | 648 | 0.000 |
Why?
|
Child, Preschool | 1 | 1986 | 42224 | 0.000 |
Why?
|
Postoperative Care | 1 | 1989 | 1468 | 0.000 |
Why?
|
Preoperative Care | 1 | 1989 | 2241 | 0.000 |
Why?
|